UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Cancer treatment reviews, ISSN 0305-7372, 2016, Volume 44, pp. 51 - 60
Hematology, Oncology and Palliative Medicine | Pembrolizumab | Immune-related adverse events | Renal cancer | Ipilimumab | Nivolumab | Lung cancer | Melanoma | Immune-checkpoint inhibitors | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Skin Neoplasms - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Adrenal Cortex Hormones - therapeutic use | Diarrhea - chemically induced | Infliximab - therapeutic use | Drug Eruptions - drug therapy | Antineoplastic Agents - adverse effects | Colitis - chemically induced | Antilymphocyte Serum - therapeutic use | Colitis - drug therapy | Carcinoma, Renal Cell - drug therapy | Chemical and Drug Induced Liver Injury - etiology | Pituitary Diseases - chemically induced | Pituitary Diseases - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Drug Eruptions - etiology | Neoplasms - drug therapy | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Melanoma - drug therapy | Chemical and Drug Induced Liver Injury - drug therapy | Diarrhea - drug therapy | CTLA-4 Antigen - antagonists & inhibitors | Kidney Neoplasms - drug therapy | Thyroiditis - drug therapy | Thyroiditis - chemically induced | Index Medicus
Journal Article
Acta veterinaria scandinavica, ISSN 0044-605X, 2014, Volume 56, Issue 1, pp. 75 - 75
Fluid therapy | Neonatal calf diarrhoea | Colostrum management | Life Sciences & Biomedicine | Veterinary Sciences | Science & Technology | Animals, Newborn | Cattle Diseases - prevention & control | Fluid Therapy - veterinary | Animals | Diarrhea - therapy | Cattle | Cattle Diseases - therapy | Diarrhea - etiology | Diarrhea - prevention & control | Diarrhea - veterinary | Colostrum - physiology | Cattle Diseases - etiology | Infants (Newborn) | Care and treatment | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 5, pp. 474 - 475
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Anti-Bacterial Agents - therapeutic use | Feces - microbiology | Diarrhea - therapy | Vancomycin - therapeutic use | Humans | Clostridium difficile | Female | Male | Care and treatment | Usage | Clostridium infections | Patient outcomes | Dosage and administration | Vancomycin | Drug therapy | Health aspects | Infusion therapy | Microbiota | Antibiotics | Fecal microflora | Intestine | Mortality | Infections | Transplantation | Intestinal microflora | Feces | Enterocolitis | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 03/2019, Volume 19, Issue 3, pp. 253 - 264
Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Salvage Therapy - adverse effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Male | RNA, Viral - blood | Treatment Outcome | Viral Load | Drug-Related Side Effects and Adverse Reactions - epidemiology | Drug-Related Side Effects and Adverse Reactions - pathology | Anti-HIV Agents - administration & dosage | Young Adult | HIV-1 - isolation & purification | Adolescent | Adult | Female | HIV Infections - drug therapy | Aged | Sustained Virologic Response | Antiretroviral Therapy, Highly Active - methods | Salvage Therapy - methods | Highly active antiretroviral therapy | Analysis | Lopinavir | DNA polymerases | Nucleosides | Adults | Product development | HIV (Viruses) | Health aspects | Health care | Slopes | Drugs | Therapy | RNA-directed DNA polymerase | Gastrointestinal tract diseases | Ritonavir | Clinical trials | Infections | Drug resistance | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Safety | Drug therapy | Active control | Failure | Public health | Antiretroviral drugs | Anemia | Diarrhea | Ribonucleic acid--RNA | Patients | Antiretroviral therapy | Studies | Lower bounds | Non-nucleoside reverse transcriptase inhibitors | Inhibitors | Algorithms | Mutation | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 25, pp. 2425 - 2437
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pyrazoles - therapeutic use | Chlorambucil - adverse effects | Chlorambucil - therapeutic use | Humans | Male | Antineoplastic Agents - therapeutic use | Fatigue - chemically induced | Diarrhea - chemically induced | Disease-Free Survival | Antineoplastic Agents - adverse effects | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Survival Analysis | Female | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - mortality | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Neutropenia - chemically induced | Pyrazoles - adverse effects | Clinical trials | Treatment outcome | Usage | Lymphocytic leukemia | Drug therapy | Analysis | Chronic lymphatic leukemia | Leukemia | Diarrhea | Fatigue | Nausea | Lymphatic leukemia | Lymphoma | Hemorrhage | Survival | Cough | Chlorambucil | Immunosuppression | Chemotherapy | Vomiting | Immunotherapy | Hemoglobin | Myelosuppression | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 3, pp. 312 - 322
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Follow-Up Studies | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Male | Survival Rate | Antineoplastic Agents - therapeutic use | Neoplasm Recurrence, Local - pathology | Urologic Neoplasms - pathology | Neoplasm Metastasis | Urologic Neoplasms - drug therapy | Carcinoma, Transitional Cell - drug therapy | Aged, 80 and over | Adult | Female | Aged | Neoplasm Staging | Platinum - pharmacology | Drug Resistance, Neoplasm - drug effects | Antimitotic agents | Chemotherapy | Carcinoma | Immunoglobulin G | Clinical trials | Product development | Metastasis | Antineoplastic agents | Cancer | Care and treatment | Analysis | Index Medicus
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 03/2012, Volume 55, Issue 3, pp. 742 - 748
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Antiviral agents | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Recombinant Proteins - therapeutic use | Isoquinolines - adverse effects | Hepatitis C - drug therapy | Humans | Middle Aged | Hepacivirus - genetics | Diarrhea - epidemiology | Male | Diarrhea - chemically induced | Polyethylene Glycols - therapeutic use | Incidence | Hepatitis C - ethnology | Treatment Failure | Protease Inhibitors - adverse effects | Adult | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Protease Inhibitors - therapeutic use | Headache - chemically induced | Antiviral Agents - therapeutic use | Imidazoles - adverse effects | Japan | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Treatment Outcome | Headache - epidemiology | Sulfonamides - therapeutic use | Antiviral Agents - adverse effects | Isoquinolines - therapeutic use | Sulfonamides - adverse effects | Aged | Viral Nonstructural Proteins - antagonists & inhibitors | Proteins | Hepatitis | Genotype & phenotype | Interferon | Infections | Index Medicus
Journal Article
Alimentary pharmacology & therapeutics, ISSN 0269-2813, 08/2015, Volume 42, Issue 4, pp. 406 - 417
Gastroenterology & Hepatology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Immunotherapy - methods | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Diarrhea - chemically induced | Infliximab - therapeutic use | Colitis - chemically induced | Melanoma - drug therapy | CTLA-4 Antigen - antagonists & inhibitors | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Algorithms | Corticosteroids | Colitis | T cells | Immunotherapy | Melanoma | Index Medicus
Journal Article